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The role of abrin, a toxic lectin isolated from seeds of Abrus precatorius Linn in inducing
apoptosis in murine Dalton’s Lymphoma Ascites (DLA) cells was evaluated. Abrin when
incubated at the concentration of 10ng per million DLA cells could bring about cell death as
typical morphological changes with apoptosis. However, necrotic cell death dominated when a
higher dose of abrin was used. DNA samples, isolated from DLA cells treated with abrin
showed fragmentation. Abrin brought about induction of apoptosis by stimulating the
expression of pro-apoptotic Caspase-3, at the same time blocking the expression of Bcl-2, which
is an anti apoptotic gene. However, the expression of tumor suppressor gene p53 has not been
observed in control and abrin-treated DLA cells. Results suggested that abrin effectively
induced apoptotic changes in the tumor cells that led to cellular death.
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Introduction
Abrus precatorius Linn which is commonly known as
Rosary pea/Jequirity bean belonging to family
Leguminosea and subfamily Papilionoidea has a toxic
glycoprotein lectin known as abrin in its seed. Three
toxins, namely abrin I, II and III and two agglutinins,
namely APA I and II, in the seeds A. precatorius, was
isolated by lactamyl Sepharose affinity chromatography
followed by gel filtration and DEAE Sephacel column
chromatography (1). Like ricin, from Ricinus communis,
abrin is also a type II ribosome inactivating protein that
inhibits protein synthesis in eukaryotic cells. The toxins
and agglutinins share high degree of sequence similarity
however, agglutinins are weaker in their activity. Some of
the other documented actions of abrin being galactose
specific (2), mitogenic (3), hemagglutinating (4), tumor-
icidal (5,6) and immunopotentiating (7,8). We have
earlier reported the in vivo tumoricidal property of
abrin against DLA and EAC (Ehrlich’s Ascites
Carcinoma)-induced solid cell tumors. It was also found
that DLA cells were more sensitive to sub lethal
doses of abrin than EAC cell line, while it spares
normal host cells (9). The susceptibility of either normal
or cancerous cells to cytotoxic insult of abrin is related
to the number of galactose specific glycosylated cell
membrane receptors (9).
In the last decade, basic cancer research has produced
remarkable advances in our understanding of cancer
biology and cancer genetics. Among the most important
of these advances is the realization that apoptosis and
the genes that control it have a profound effect on the
malignant phenotype. For example, it is now clear that
some oncogenic mutations disrupt apoptosis, leading to
tumor initiation, progression or metastasis. Conversely,
compelling evidence indicates that other oncogenic
changes promote apoptosis, thereby producing selective
pressure to override apoptosis during multistage carcino-
genesis. The life span of both normal and cancer cells
within a living system are regarded to be substantially
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properly cited.affected by rate of apoptosis. In addition, apoptosis is
a discrete way of cell death, different from necrotic
cell death and is regarded as an ideal way of cell
elimination. In recent years, many cancer chemothera-
peutic agents have been shown to induce apoptosis
(10–12) and conversely, several tumor promoters have
also been shown to inhibit apoptosis (13). Like abrin,
agglutinin-I also induces apoptosis in cells by triggering
the intrinsic mitochondrial pathway, though at higher
concentrations as compared to abrin (14,15). There are
pro-apoptotic genes (e.g. Caspase-3, 8, 9) and anti-
apoptotic genes (e.g. Bcl-2, Bcl-xL, Bcl-w) within a cell
and the expression of each group of genes are tightly
regulated by a complex mechanism. The objective of
the present study is to evaluate the role of abrin, a
toxic lectin from A. precatorius, in inducing apoptosis in
murine DLA cells.
Methods
Drug Preparation
Abrin was isolated from seeds of red variety of
A. precatorius using Sepharose 4B affinity column
chromatography and purified as per an earlier report
(16). The stock solution so obtained, was diluted with
Phosphate Buffered Saline (PBS, pH 7.2) to get a
concentration of 250ng ml
1.
Cell Culture
DLA cell line was obtained from Adayar Cancer Institute
(Chennai, India) and was propagated as transplantable
ascites tumors in female Swiss albino mice. Cells were
aspirated freshly from mouse peritoneum, washed with
PBS and the concentration determined using hemocyt-
ometer. Viability of cells was checked by the dye
exclusion method using trypan blue (1%). Five million
live cells were added to 15ml of Dulbeco’s Minimum
Essential Medium (DMEM) supplemented with 10%
fetal calf serum in culture flasks and maintained at
37C in 5% CO2 atmosphere.
Cytotoxicity of Abrin
Two concentrations of abrin namely 10 and 25ng per
million DLA cells were utilized for culture in triplicate.
A control culture of DLA cells alone in triplicate was
also maintained. After adding the drug, 48h incubation
was allowed. Following these treatments, cells were
washed thrice with PBS and tested for viability by
using dye exclusion method in order to test the toxicity of
abrin. Cell pellet was aspirated following centrifugation.
To study morphological changes, a small portion of
the pellet was resuspended in PBS and cell smear was
prepared and stained with hematoxylin and eosin. The
numbers of normal and apoptotic cells were counted
from the stained smears.
Isolation of Genomic DNA and Analysis
of DNA Fragmentation
The DLA cells incubated with different drug concentra-
tions for 48h were washed twice with Tris borate saline
(TBS), centrifuged at 300RPM. for 10min and the
supernatant was discarded. The pellet was washed and
resuspended in saline EDTA (SE) buffer. Later 20mlo f
proteinase K (20mg ml
1) and 50ml of 20% SDS were
added and mixed. The digested sample was cooled to
room temperature and 100ml of 5M NaCl was added and
mixed. Saturated phenol (pH 7.8) was added in equal
volume, mixed and centrifuged at 4000RPM. for 15min.
The aqueous phase was collected in fresh tube. A mixture
of saturated phenol:chloroform:isoamyl alcohol
(25:24:1) was added in equal volume and mixed and
centrifuged at 4000RPM. for 15min. The aqueous phase
was transferred in fresh tube. An equal volume of
chloroform: isoamyl alcohol (24:1) was mixed and
centrifuged. The aqueous phase was then transferred to
a sterile 100ml beaker added one-tenth volume of 3M
sodium acetate (pH 5.5) was added and mixed well.
Equal volume of isopropanol was added and the
precipitated DNA was pooled out on clean micropipette
tip, washed with 70% ethanol, air dried and resuspended
in TE buffer (pH 8.0). Purity and quantification of the
DNA was carried out by monitoring the ODs at 260
and 280nm. Ten microliter (50ng) of each samples were
resolved at 100V for 2h on a 2% agarose gel containing
0.5mgml
1 ethidium bromide. A 100bp ladder DNA
sample was used as marker. The resulting DNA
fragmentation was visualized under UV transilluminator
followed by polaroid photography in gel documentation
unit (Vilber Lourmat, France).
Preparation of cDNA
The cDNA was prepared from cell lysate without RNA
isolation (17). A total of 110
4 DLA cells were
suspended in serum free DMEM (250ml) and incubated
in the microtiter plate for 12h. Abrin, at a concentration
of 0.1ng per well was added and incubated for 4h.
The medium was aspirated and 200ml ice cold PBS was
added. The PBS was aspirated before adding 100ml ice
cold cell lysis buffer. This was then transferred to a water
bath at 75C and incubated for 15min and the cell lysate
transferred to 200ml PCR vials. Two Microliter DNase-I
per 100ml cell lysis buffer was added and incubated for
15min at 37C. The DNase was inactivated by heating to
75C for 15min in a water bath. To the 10ml of cell
lysate (RNA) 4ml of dNTP mixture, 2ml of Oligo (dT)18
primer and 16ml of nuclease free water were added,
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70C in a water bath. Then this was placed on ice for
1min. Later 1ml of M-MLV Reverse Transcriptase (RT),
2mlo f1 0 RT buffer and 1ml of RNase inhibitor
were added. The final mixture was incubated at 42C
for 60min, followed by 95C for 10min to inactivate
the RT.
Reverse Transcriptase (RT)–Polymerase Chain Reaction
(PCR) for the Amplification of Caspase-3, Bcl-2 and p53
The RT–PCR was carried out for p53: tumor suppressor
gene (Maxim Biotech. Inc., SF, USA). The pre-mixed
primer of 250ml was added to PCR buffer (750ml)
containing enhancer, stabiliser and dNTPs to make
master mixture according to the manufacturer’s instruc-
tion. Master mixture (39ml), Taq DNA polymerase (1ml)
and specimen/control cDNA (10ml) were mixed and PCR
reaction was carried out in the minicycler (MJ Research,
Germany).
One-tenth of the amplified samples were electropho-
resised in an agarose gel containing 0.5mgm l
1 ethidium
bromide. Similarly RT–PCR procedure was carried out
for Caspase-3 and Bcl-2 (Maxim Biotech. Inc., SF, USA)
and the house keeping gene Glyceraldehyde phosphate
dehydrogenase (GAPDH) (Biosource International Inc.
USA) as per the manufacturer’s instructions.
Agarose Gel Electrophoresis for DNA/PCR
Products Separation
To 1g agarose in 5ml of 10Tris borate EDTA (TBE)
buffer (pH 8.0), 50ml of double distilled water was added
and boiled until all the agarose was dissolved. This was
allowed to cool to 50C. Sufficient ethidium bromide,
was added to get a final concentration of 0.5mgm l
1 of
gel. The gel was casted and placed in the electrophoresis
apparatus containing enough 1TBE buffer and
0.5mg/ml ethidium bromide to cover the gel. Ten
microliter of DNA sample per 10ml of PCR product
per 10ml of DNA molecular weight marker was mixed
with 2mlo f6 gel loading buffer (0.25% bromphenol
blue, 30% glycerol). Each 12ml of these samples were
loaded into wells. Samples were run at 100V for 2h or
until the dye had migrated three-fourth of the gel. Results
were read in a gel documentation unit.
Results
Cytotoxicity of Abrin
Viable cells which remained unstained by trypan blue
were counted in a hemocytometer. The number of dead
cells encountered with abrin treatment at 10 and 25ng
per million DLA cells were 405 and 535, whereas
control cultures exhibited 224 dead cells. This result
emphasized abrin’s cytotoxic nature, which was dose
dependent (Table 1).
Apoptotic Cells Versus Necrotic Cells
Microscopic examination of abrin-treated and control
DLA cells revealed that the cell death could be either
with necrotic or with apoptotic characteristics. On
studying the morphology of cultured DLA cells, necrotic
cells were identified as swollen, disintegrating with more
eosinophilic cytoplasm, pale nucleus but conserved
chromatin. While apoptotic cells were distinguished as
highly condensed/shrunken cell with nuclear elongation,
margination, fragmentation and sacculation, cell blebbing
and presence of apoptotic bodies. Active normal DLA
cells were characterized by less eosinophilic cytoplasm
and nucleus with uniform distribution of chromatin
material. The proportion of DLA cells with apoptotic
changes was approximately double when compared to
necrotic cells in cultures containing 10ng abrin per
million DLA cells. However, in the culture having 25ng
abrin, the number of DLA cells with apoptotic and
necrotic changes were 39323 and 33131 per 10
3 cells,
respectively (Table 1).
DNA Fragmentation
Results of electrophoretic run of DNA samples (Fig. 1)
showed that abrin-treated DLA cells exhibited extensive
double strand breaks; thereby yielding a ladder appear-
ance (lane 5), while the DNA of control DLA cells
exhibited minimum breakage (lane 3). The DNA isolated
from fresh DLA cells did not show any double strand
breaks (lane 2). The DNA isolated from DLA cells
treated with 10ng abrin showed more fragmentation than
those treated with 25ng abrin (lane 4). This kind of DNA
cleavage is one of the characteristics of apoptosis.
Apoptotic Gene Expressions in Abrin-treated DLA Cells
On electrophoresis, bands corresponding to 205 base
pairs in size indicated the presence of target sequences in
the specimens for p53 (Fig. 2), 414 base pairs for
Caspase-3 (Fig. 2), 235 base pairs for Bcl-3 (Fig. 3) and
Table 1. Assessment of cytotoxicity of abrin on DLA cells (n=3)
Concentration
of abrin per 10
6
DLA cells
% dead cells
after 48h
Number of
apoptotic cells
per 10
3
DLA cells
Number of
necrotic cells
per 10
3
DLA cells
02 2 43 3 4 23427
10ng 405 57037 28014
25ng 535 39323 33131
Values are meanSE.
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and 3). Results of the present study indicated that in vitro
treatment with abrin at a concentration of 0.1ng per
110
4 DLA cells resulted in the selective expression of
the pro-apoptotic gene Caspase-3 (Fig. 2, lane 2). Control
cells did not exhibit the expression of this gene (Fig. 2,
lane 1). Treatment with abrin led to the suppression of
Bcl-2 expression (Fig. 3, lane 2), which is an anti-
apoptotic gene. Control DLA cells showed the expression
of Bcl-2 (Fig. 3, lane 1). Though expression of GAPDH
could be obtained in all (Fig. 2, lane 7 and Fig. 3, lane 4),
the band corresponding to p53 gene expression could not
be noticed in any of the cell lines screened.
Discussion
Anti-tumor agents, which can modulate apoptosis, may
be able to affect the steady state of cell populations that
are helpful in the management and therapy of cancer.
Results of the present study suggested that abrin could
induce tumor cell death both by physiological or
pathological means. Most of the cytotoxic anti-cancer
drugs in current use have been shown to induce apoptosis
in susceptible cells. It has been established that apoptotic
cells display DNA fragmentation at internucleosomal
sites followed by morphological changes and loss of
membrane integrity (18,19).
Figure 1. Electrophoretic separation of DNA samples of DLA cells
treated with abrin. Lane 1: DNA molecular weight markers, lane 2:
DNA isolated from fresh DLA cells, lane 3: DNA isolated from culture
of untreated DLA cells, lane 4: DNA isolated from abrin-treated (25ng
per million) DLA cells and lane 5: DNA isolated from abrin-treated
(10ng per million) DLA cells.
Figure 2. Electrophoretic separation of RT–PCR samples. Lane 1: PCR
product from control DLA cells for Caspase-3, lane 2: PCR product
from abrin-treated DLA cells for Caspase-3, lane 3: PCR product from
positive control for Caspase-3, lane 4: PCR product from control DLA
cells for p53, lane 5: PCR product from abrin-treated DLA cells for
p53, lane 6: PCR product from positive control for p53, lane 7: PCR
product from control DLA cells for GAPDH and lane 8: 100bp
molecular weight marker.
Figure 3. Electrophoretic separation of RT–PCR samples. Lane 1: PCR
product from control DLA cells for Bcl-2, lane 2: PCR product from
abrin-treated DLA cells for Bcl-2, lane 3: PCR product from positive
control for Bcl-2, lane 4: PCR product from control DLA cells for
GAPDH and lane 5: 100bp molecular weight marker.
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A-chain and lectin B-chain, held together by disulfide
bonds. The toxic A-chain of abrin is capable of
deactivating each and every ribosome in the cell, which
culminates in cell death. The lectin part of toxin molecule
(B-chain) is liable for recognition of cell surface and
binding. Having bound diffusely to the cell membrane,
the protein is internalized by way of receptor mediated
endocytosis (20). Like abrin, other galactose specific
lectins like ricin, is reported to induce apoptosis in target
cells by inhibiting protein synthesis (21), and specific
lectin from Viscum album L, namely ML I brings about
apoptosis in peripheral lymphocytes (22). This study
revealed that the potency of abrin to bring about
apoptotic changes decreases with dose, as more cell
death through necrotic pathway dominated when 25ng of
abrin was present in the culture in place of 10ng per 1
million cells. Such a kind of dose-dependent cytotoxicity
was recently reported on T-lymphocytes by Viscum album
agglutinin –I (23).
From this study we establish that nuclear changes,
as a part of apoptosis precedes the loss of membrane
integrity thereby making trypan blue impermeable.
More than 50% of DLA cells incubated with abrin
showed intact cell membrane responding as live cells in
the dye exclusion test, but DNA fragmentation could be
detected at that time. This finding closely agreed with
earlier reports (24,25), suggesting that DNA cleaveage of
abrin-treated cells occurs before loss of membrane
integrity. It was earlier reported that a good positive
correlation existed between agglutinating activity of
abrin-a and development of apoptosis to DNA fragmen-
tation. The B-chain probably triggers the apoptosis, while
the A-chain and breakage of the disulfide bond are
responsible for its progress on leukemia cell lines (26).
We reported earlier that abrin when administered in
mice at7.5mgk g
1 body weight (one tenth LD50) i.p., on
every alternate day for 10 days, could effectively reduce
solid tumor mass development and also increase the life
span of ascites tumor bearing mice. The above sublethal
dose of abrin caused no significant change in body weight
gain or in the hematological profiles like total erythrocyte
count, total leukocyte count and hemoglobin concentra-
tion in normal mice (9). Moreover, mice that received
the safe dose of abrin exhibited no significant change
in activities of certain serum enzymes such as alanine
amino transferase, aspartate amino transferase and
Alkaline phosphatase as well as in the levels of certain
serum metabolites such as urea nitrogen, creatinine and
bilirubin.
When compared to normal cells, tumor cells possess
abundant glycosylated binding sites on the cell surface
(27); cells require lesser number of abrin molecules for
initiating cell death. Abrin is highly toxic to Epstein Barr
Virus (EBV) transformed lymphocytes when compared
to normal lymphocytes (28). Such varying responses of
different cells to the toxic abrin may be due to several
factors including relative number of abrin binding sites
on cell surface and the rate of degradation of internalized
toxin.
However, sensitivities of cells to abrin do not necessarily
correlate with their normal state as exhibited by mouse
embryonic fibroblasts (MEF) and untransformed mouse
cell line (NIH 3T3) or with their neoplastic state as
encountered with two mouse tumor cell lines namely
LMTK and S-180 (26). NIH 3T3 and LMTK cells had
significantly fewer abrin binding sites than MEF and S-180
cells while, the degradation of internalized abrin was more
rapid in NIH 3T3 and S-180 cells than in LMTK and MEF
cells. The induction of apoptosis in tumor cells make them
render more for host phagocytic clearance without initiat-
ing inflammation which could also be attributed for abrin’s
tumouricidal activity. The possible reasons for abrin
causing moderate toxicity to normal healthy cells while
bringing about severe cytotoxicity against cancerous cells
should be investigated thoroughly.
The p53, also known as TP53 is a gene that codes for a
protein that regulates the cell cycle and hence functions
as a tumor suppressor. It is very important for a cell in
multicellular organisms to suppress cancer.The p53 has
conserving stability of the cell by preventing genome
mutation (29). In cancerous cells, the expression of p53
is much suppressed and in the present study even control
DLA cells did not exhibit its expression. The loss of this
protein due to mutation is a primary event in the
formation of many types of leukemias, breast cancer,
colon, lung and liver. Bcl-2 was first discovered as a
translocated locus [t(14;22)] in B-cell leukemias, and
is an anti-apoptotic protein that protects cells from
programmed cell death by preventing the activation of
pro-apoptotic Caspase proteins like Bax, Bak and Bok.
Caspase-3 is an enzyme that plays a key role in
programmed cell death and is a member of the family
of aspartate specific cysteinyl proteases.
Results of this study showed that pre-treatment of
DLA cells with abrin at a low sublethal dose brought
about induction of apoptosis chiefly by stimulating the
expression of Caspase-3, at the same time blocking the
expression of Bcl-2. It was earlier reported that release of
mitochondrial cytochrome c, and the sequential Caspase-
9 and Caspase-3 activations were important events in the
signal transduction pathway of abrin-induced apoptotic
cell death in the HeLa cell line (30) and their observation
closely agreed with our results. Regarding the activation
of Caspase-3 for initiation of apoptosis, our results fully
agreed with an earlier report (31), which claimed that,
the apoptotic pathway induced by abrin was Caspase
3-dependent but Caspase 8-independent. It is generally
considered that Caspase 3-dependent apoptosis involves
mitochondrial membrane potential damage and reactive
oxygen species production. Abrin effectively induceing
apoptotic changes in tumor cells leading to cellular death
eCAM 2009;6(2) 237have been scientifically proved through systematic
electrophoretic analysis, and the product under study
appears to be promising for clinical trials. So abrin as
a new potential anti-cancer agent is very promising.
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